2 employees
BioInno is a provider of CDMO process development and GMP production services to pharmaceutical companies.
2019
BioInno Bioscience Co., Ltd. raised undisclosed on December 21, 2021
Investors: BridgeOne Capital, Efung Capital and Tigermed